Clinical Trial Update: Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending-dose study of the investigational compound BMS-820132 in patients with Type 2 diabetes mellitus has completed. The trial was conducte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-820132

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED